Schonfeld Strategic Advisors LLC Mannkind Corp Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Mannkind Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 474,019 shares of MNKD stock, worth $3.15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

474,019

Previous 910,996 47.97%

Holding current value

$3.15 Million

Previous $4.13 Million 40.04%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.05 - $5.43 $1.77 Million - $2.37 Million	-436,977 Reduced 47.97%	474,019 $2.47 Million
Q1 2024 May 15, 2024	SELL	$3.25 - $5.27 $337,649 - $547,510	-103,892 Reduced 10.24%	910,996 $4.13 Million
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $139,237 - $178,841	41,688 Added 4.28%	1,014,888 $3.69 Million
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $348,009 - $485,077	89,005 Added 10.07%	973,200 $4.02 Million
Q2 2023 Aug 14, 2023	BUY	$3.72 - $4.79 $138,313 - $178,096	37,181 Added 4.39%	884,195 $3.6 Million
Q1 2023 May 15, 2023	SELL	$3.95 - $5.63 $7.96 Million - $11.3 Million	-2,015,886 Reduced 70.41%	847,014 $3.47 Million
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $252,677 - $449,297	83,668 Added 3.01%	2,862,900 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $1.02 Million - $1.49 Million	341,603 Added 14.01%	2,779,232 $8.59 Million
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $2.85 Million - $5.09 Million	1,067,829 Added 77.96%	2,437,629 $9.29 Million
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $61,308 - $104,130	23,400 Added 1.74%	1,369,800 $5.04 Million
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $692,550 - $918,270	171,000 Added 14.55%	1,346,400 $5.88 Million
Q3 2021 Nov 16, 2021	SELL	$3.89 - $5.48 $4.79 Million - $6.74 Million	-1,230,400 Reduced 51.14%	1,175,400 $5.11 Million
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $3.66 Million - $5.52 Million	1,013,689 Added 72.82%	2,405,800 $13.1 Million
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $4.2 Million - $8.21 Million	1,336,983 Added 2425.23%	1,392,111 $5.46 Million
Q4 2020 Feb 16, 2021	SELL	$1.79 - $4.04 $258,962 - $584,474	-144,672 Reduced 72.41%	55,128 $173,000
Q3 2020 Nov 16, 2020	SELL	$1.56 - $2.08 $141,024 - $188,032	-90,400 Reduced 31.15%	199,800 $0
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $272,788 - $641,342	290,200 New	290,200 $508,000
Q1 2020 May 15, 2020	SELL	$0.84 - $1.76 $33,852 - $70,928	-40,300 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.14 - $1.49 $697,793 - $912,029	-612,100 Reduced 93.82%	40,300 $52,000
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.44 $678,496 - $939,456	652,400 New	652,400 $815,000

Others Institutions Holding MNKD

# of Institutions

222

Shares Held

133M

Call Options Held

1.43M

Put Options Held

851K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.71B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Mannkind Corp Transaction History